Tumour Assessment for Molecular Testing
As genomic testing becomes more routine for cellpath labs, there is an increased need for assessment of the tumour content for the more complex tests in particular, in order to ensure there is enough tumour material to ensure the test result is valid. Tumour tissue however is mixed, usually containing both tumour and non-tumour cells. Tumours are also heterogenous, with some areas more relevant for a given test than others. For this reason, the region of tumour that the DNA/ RNA is extracted from must be assessed to ensure it is suitable and contains a sufficient amount of tumour cells for genomic analysis. This course has been developed for histopathologists, clinical scientists and biomedical scientists involved in the selection of tumour samples for genomic testing.
Download as vCalendar (for Microsoft Outlook etc.)
NEPSEC - Wakefield
Training Centre Manager
Manchester Cytology Centre
Manchester Royal Infirmary
Oxford Road M13 9WL